Associations of Cardiovascular-Kidney-Metabolic Syndrome with Premature Mortality and Life Expectancies in US Adults: A Cohort Study
Cardiorenal Medicine · 01.07.2025 · 15 (1) · 484-495
DOI: 10.1159/000546618 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cardiorenal Medicine, online erschienen am 01.07.2025. Verfasst von Lubi Lei und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medica…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Life Expectancy, Mortality, Premature, Cardiovascular Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The American Heart Association has recently updated the Cardiovascular-Kidney-Metabolic (CKM) Health Advisory, proposing a new framework for defining, staging, and predicting CKM risk. However, the prevalence and adverse effects of the CKM stages remain insufficiently characterized.
Methods
We analyzed data from the National Health and Nutrition Examination Survey (NHANES) (1999–2018), including 18,350 US adults aged 20–79 years. CKM syndrome encompasses subclinical or clinical cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic risk factors. The participants were categorized into 4 CKM stages based on their clinical severity. We assessed associations of CKM stages with mortality risk and life expectancy.
Results
Only 12.9% of participants were classified as having CKM stage 0. The prevalence of CKM stages 1, 2, 3, and 4 was 23.1%, 53.6%, 3.6%, and 6.7%, respectively. Compared with CKM stage 0, individuals in stage 4 had a markedly higher risk of all-cause mortality (HR: 4.30, 95% CI: 2.95–6.26) and lost 15.5 (12.5–19.8) years of life at age 50 years. Sex and racial/ethnic disparities were also observed.
Conclusions
A higher CKM stage was strongly associated with increased mortality and reduced life expectancy. Our findings underscore the urgent need for enhanced CKM health management, social support, and policy intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, lijingkuo…
- Center for Clinical and Epidemiologic Research, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, The Key Laboratory of Remodeling-Related Cardiovascular Di…
- Cardio-Metabolic Medicine Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Zitieren
APA
Lei, L., Li, J., Ding, W., Wang, W., Yu, Y., Pu, B., Peng, Y., Zhang, L., & Guo, Y. (2025). Associations of Cardiovascular-Kidney-Metabolic Syndrome with Premature Mortality and Life Expectancies in US Adults: A Cohort Study. Cardiorenal Medicine, 15(1), 484-495. https://doi.org/10.1159/000546618
Vancouver
Lei L, Li J, Ding W, Wang W, Yu Y, Pu B, et al. Associations of Cardiovascular-Kidney-Metabolic Syndrome with Premature Mortality and Life Expectancies in US Adults: A Cohort Study. Cardiorenal Medicine. 2025;15(1):484-495. doi:10.1159/000546618
BibTeX
@article{Lei2025,
author = {Lei, Lubi and Li, Jingkuo and Ding, Wenbo and Wang, Wei and Yu, Yanwu and Pu, Boxuan and Peng, Yue and Zhang, Lihua and Guo, Yuanlin},
title = {Associations of Cardiovascular-Kidney-Metabolic Syndrome with Premature Mortality and Life Expectancies in US Adults: A Cohort Study},
journal = {Cardiorenal Medicine},
year = {2025},
volume = {15},
number = {1},
pages = {484--495},
doi = {10.1159/000546618}
}
EUVIMED